UPDATE: Goldman Sachs Downgrades Myriad Genetics (MYGN) to Sell
Tweet Send to a Friend
(Updated - March 26, 2015 10:09 AM EDT)
Goldman Sachs downgraded Myriad Genetics (NASDAQ: MYGN) from Neutral to Sell ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs downgraded Myriad Genetics (NASDAQ: MYGN) from Neutral to Sell ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
